Protherics’ DigiFab™ to Become Market Leader in Europe

By Business Review Editor

Pharma Deals Review: Vol 2007 Issue 79 (Table of Contents)

Published: 7 Jan-2007

DOI: 10.3833/pdr.v2007.i79.405     ISSN: 1756-7874

Section: Licensing

Fulltext:

Abstract

Protherics expanded its core franchise through the transfer of the market rights for Digitalis Antidot® from Roche...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details